相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。BloodSpot: a database of healthy and malignant haematopoiesis updated with purified and single cell mRNA sequencing profiles
Frederik Otzen Bagger et al.
NUCLEIC ACIDS RESEARCH (2019)
Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies
Steven E. Coutre et al.
BLOOD ADVANCES (2019)
Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemia
Laurie Freire Boullosa et al.
ONCOTARGET (2018)
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Joseph A. Fraietta et al.
NATURE MEDICINE (2018)
New Approaches to the Management of Adult Acute Lymphoblastic Leukemia
Renato Bassan et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Survivin as a novel target protein for reducing the proliferation of cancer cells (Review)
Dongyu Li et al.
BIOMEDICAL REPORTS (2018)
The ABCs of Immunotherapy for Adult Patients With B-Cell Acute Lymphoblastic Leukemia
Troy Z. Horvat et al.
ANNALS OF PHARMACOTHERAPY (2018)
Treatment of Older Patients with Acute Lymphoblastic Leukaemia
Nicola Goekbuget
DRUGS & AGING (2018)
Ibrutinib inhibits pre-BCR+ B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK
Ekaterina Kim et al.
BLOOD (2017)
Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia
Guoqing Wei et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Acute lymphoblastic leukemia: a comprehensive review and 2017 update
T. Terwilliger et al.
BLOOD CANCER JOURNAL (2017)
B lymphoblastic leukemia/lymphoma: new insights into genetics, molecular aberrations, subclassification and targeted therapy
Xiaohui Zhang et al.
ONCOTARGET (2017)
Cellular Immunotherapy in B-Cell Malignancy
Mark-Alexander Schwarzbich et al.
ONCOLOGY RESEARCH AND TREATMENT (2017)
Progress in adult ALL: incorporation of new agents to frontline treatment
Jessica Leonard et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2017)
Acute Lymphoblastic Leukemia in Adolescents and Young Adults
Michael E. Rytting et al.
CANCER (2017)
Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
D. Hoelzer et al.
ANNALS OF ONCOLOGY (2016)
Survivin: a unique target for tumor therapy
Himani Garg et al.
CANCER CELL INTERNATIONAL (2016)
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
John C. Byrd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
Hagop M. Kantarjian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
B-Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
Sanam Loghavi et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis
Suzanne E. Brooks et al.
PLOS ONE (2015)
Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitor
W. Guo et al.
CELL DEATH & DISEASE (2014)
Discovery of a Selective Irreversible BMX Inhibitor for Prostate Cancer
Feiyang Liu et al.
ACS CHEMICAL BIOLOGY (2013)
Targeting B-Cell Receptor Signaling for Anticancer Therapy: The Bruton's Tyrosine Kinase Inhibitor Ibrutinib Induces Impressive Responses in B-Cell Malignancies
Adrian Wiestner
JOURNAL OF CLINICAL ONCOLOGY (2013)
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
Michael L. Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Multifunctional T-cell Analyses to Study Response and Progression in Adoptive Cell Transfer Immunotherapy
Chao Ma et al.
CANCER DISCOVERY (2013)
Applications of Next-Generation Sequencing to Blood and Marrow Transplantation
Michael Chapman et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Cancer-Testis Antigens Expressed in Osteosarcoma Identified by Gene Microarray Correlate With A Poor Patient Prognosis
Changye Zou et al.
CANCER (2012)
Deletion of the Endothelial Bmx Tyrosine Kinase Decreases Tumor Angiogenesis and Growth
Tanja Holopainen et al.
CANCER RESEARCH (2012)
BMX and Its Role in Inflammation, Cardiovascular Disease, and Cancer
Bruno Cenni et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2012)
Integrative Epigenomic Analysis Identifies Biomarkers and Therapeutic Targets in Adult B-Acute Lymphoblastic Leukemia
Huimin Geng et al.
CANCER DISCOVERY (2012)
The Tyrosine Kinase BMX Is an Essential Mediator of Inflammatory Arthritis in a Kinase-Independent Manner
Marie Gottar-Guillier et al.
JOURNAL OF IMMUNOLOGY (2011)
Elevated expression levels of testis-specific genes TEX101 and SPATA19 in basal cell carcinoma and their correlation with clinical and pathological features
S. Ghafouri-Fard et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Adult Acute Lymphoblastic Leukemia Concepts and Strategies
Stefan Faderl et al.
CANCER (2010)
Compensatory Upregulation of Tyrosine Kinase Etk/BMX in Response to Androgen Deprivation Promotes Castration-Resistant Growth of Prostate Cancer Cells
Bojie Dai et al.
CANCER RESEARCH (2010)
Elevated expression of the leukemia-associated antigen SSX2IP predicts survival in acute myeloid leukemia patients who lack detectable cytogenetic rearrangements
Barbara Guinn et al.
BLOOD (2009)
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2009)
Clinical stage EGFR inhibitors irreversibly alkylate Bmx kinase
Wooyoung Hur et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
SSX2IP expression in acute myeloid leukaemia: an association with mitotic spindle failure in t(8;21), and cell cycle in t(15;17) patients
Barbara-ann Guinn et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Cancer immunomics using autoantibody signatures for biomarker discovery
Michel Caron et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
New therapeutic strategies for the treatment of acute lymphoblastic leukaemia
Ching-Hon Pui et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
A novel MHC-associated Proteinase 3 peptide isolated from primary chronic myeloid leukaemia cells further supports the significance of this antigen for the immunotherapy of myeloid leukaemias
AJ Knights et al.
LEUKEMIA (2006)
Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia
B Guinn et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Serologic detection of diffuse large B-cell lymphoma-associated antigens
AP Liggins et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Identification and validation of cell surface antigens for antibody targeting in oncology
P Carter et al.
ENDOCRINE-RELATED CANCER (2004)
Frequent expression of HAGE in presentation chronic myeloid leukaemias
SP Adams et al.
LEUKEMIA (2002)
Signaling network of the Btk family kinases
Y Qiu et al.
ONCOGENE (2000)
分享论文
